We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Mediclinic International Plc | LSE:MDC | London | Ordinary Share | GB00B8HX8Z88 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 501.00 | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMMDC
RNS Number : 3423H
Mediclinic International plc
06 June 2017
Mediclinic International plc
(Incorporated in England and Wales)
Company Number: 08338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88
LEI: 2138002S5BSBIZTD5I60
("Mediclinic", the "Company" or the "Group")
6 June 2017
NOTIFICATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
Vesting of awards under the Company's Forfeitable Share Plan
The awards of ordinary shares in Mediclinic (the "Shares") set out in the table below, granted on 31 July 2014, vested under the Company's Forfeitable Share Plan on 31 May 2017.
Name Director/ Number Number Number PDMR of Shares of Shares of Shares vested sold at retained(1) ZAR 130.44 per share --------------------- ----------- ----------- ------------ ------------- Danie Meintjes Director 49,423 0 49,423 --------------------- ----------- ----------- ------------ ------------- Gert Hattingh PDMR 14,734 0 14,734 --------------------- ----------- ----------- ------------ ------------- Koert Pretorius PDMR 19,806 19,806 0 --------------------- ----------- ----------- ------------ ------------- David Hadley PDMR 9,778 9,778 0 --------------------- ----------- ----------- ------------ ------------- Dr Ole Wiesinger(1) PDMR 17,506 0 17,506 --------------------- ----------- ----------- ------------ ------------- Dr Ronnie van der Merwe PDMR 16,507 16,507 0 --------------------- ----------- ----------- ------------ -------------
1. Dr Wiesinger was granted a conditional right to 17,506 Shares under the Country Schedule to the Forfeitable Share Plan on 31 July 2014. On 1 June 2017, Dr Wiesinger elected to receive the award in Shares, which he received on 5 June 2017.
The following notification made in accordance with Articles 19.1 and 19.3 of the Market Abuse Regulation relates to the Company's Forfeitable Share Plan.
1. Details of PDMR / person closely associated with them ("PCA") --- ------------------------------------------------------------- a) Name Daniël Petrus Meintjes --- --------------------- -------------------------------------- 2. Reason for the notification --- ------------------------------------------------------------- a) Position Chief Executive Officer of the / status Company --- --------------------- -------------------------------------- b) Initial notification Initial Notification / amendment --- --------------------- -------------------------------------- 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- ------------------------------------------------------------- a) Name Mediclinic International plc --- --------------------- -------------------------------------- b) LEI 2138002S5BSBIZTD5I60 --- --------------------- -------------------------------------- 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- ------------------------------------------------------------- a) Description Ordinary Shares of the financial instrument GB00B8HX8Z88 Identification Code --- --------------------- -------------------------------------- b) Nature of Vesting of award over 49,423 ordinary the transaction shares awarded under the Company's Forfeitable Share Plan --- --------------------- -------------------------------------- c) Price(s) Price(s) Volume(s) and volume(s) ---------- ---------- Nil cost 49,423 ---------- ---------- --- --------------------- -------------------------------------- d) Aggregated information Aggregated volume 49,423 Price Nil cost --- --------------------- -------------------------------------- e) Date of the 1 June 2017 transaction --- --------------------- -------------------------------------- f) Place of Johannesburg Stock Exchange the transaction --- --------------------- -------------------------------------- 1. Details of PDMR / person closely associated with them ("PCA") --- ------------------------------------------------------------- a) Name Gert C Hattingh --- --------------------- -------------------------------------- 2. Reason for the notification --- ------------------------------------------------------------- a) Position Chief Corporate Services Officer / status of the Company --- --------------------- -------------------------------------- b) Initial notification Initial Notification / amendment --- --------------------- -------------------------------------- 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- ------------------------------------------------------------- a) Name Mediclinic International plc --- --------------------- -------------------------------------- b) LEI 2138002S5BSBIZTD5I60 --- --------------------- -------------------------------------- 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- ------------------------------------------------------------- a) Description Ordinary Shares of the financial instrument GB00B8HX8Z88 Identification Code --- --------------------- -------------------------------------- b) Nature of Vesting of award over 14,734 ordinary the transaction shares awarded under the Company's Forfeitable Share Plan --- --------------------- -------------------------------------- c) Price(s) Price(s) Volume(s) and volume(s) ---------- ---------- Nil cost 14,734 ---------- ---------- --- --------------------- -------------------------------------- d) Aggregated information Aggregated volume 14,734 Price Nil cost --- --------------------- -------------------------------------- e) Date of the 1 June 2017 transaction --- --------------------- -------------------------------------- f) Place of Johannesburg Stock Exchange the transaction --- --------------------- -------------------------------------- 1. Details of PDMR / person closely associated with them ("PCA") --- ------------------------------------------------------------ a) Name Koert Hendrik S Pretorius --- --------------------- ------------------------------------- 2. Reason for the notification --- ------------------------------------------------------------ a) Position Chief Executive Officer - Mediclinic / status Southern Africa --- --------------------- ------------------------------------- b) Initial notification Initial Notification / amendment --- --------------------- ------------------------------------- 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- ------------------------------------------------------------ a) Name Mediclinic International plc --- --------------------- ------------------------------------- b) LEI 2138002S5BSBIZTD5I60 --- --------------------- ------------------------------------- 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- ------------------------------------------------------------ a) Description Ordinary Shares of the financial instrument GB00B8HX8Z88 Identification Code --- --------------------- ------------------------------------- b) Nature of 1. Vesting of award over 19,806 the transaction ordinary shares awarded under the Company's Forfeitable Share Plan 2. Sale of 19,806 ordinary shares. --- --------------------- ------------------------------------- c) Price(s) Price(s) Volume(s) and volume(s) --------------- ---------- 1. Nil cost 1. 19,806 --------------- ----------
2. ZAR 130.44 2. 19,806 --------------- ---------- --- --------------------- ------------------------------------- d) Aggregated 1. 19,806 information Aggregated 2. 19,806 volume Price 1. Nil cost 2. ZAR 130.44 --- --------------------- ------------------------------------- e) Date of the 1 June 2017 transaction --- --------------------- ------------------------------------- f) Place of Johannesburg Stock Exchange the transaction --- --------------------- ------------------------------------- 1. Details of PDMR / person closely associated with them ("PCA") --- ------------------------------------------------------------ a) Name David J Hadley --- --------------------- ------------------------------------- 2. Reason for the notification --- ------------------------------------------------------------ a) Position Chief Executive Officer - Mediclinic / status Middle East --- --------------------- ------------------------------------- b) Initial notification Initial Notification / amendment --- --------------------- ------------------------------------- 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- ------------------------------------------------------------ a) Name Mediclinic International plc --- --------------------- ------------------------------------- b) LEI 2138002S5BSBIZTD5I60 --- --------------------- ------------------------------------- 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- ------------------------------------------------------------ a) Description Ordinary Shares of the financial instrument GB00B8HX8Z88 Identification Code --- --------------------- ------------------------------------- b) Nature of 1. Vesting of award over 9,778 the transaction ordinary shares awarded under the Company's Forfeitable Share Plan 2. Sale of 9,778 ordinary shares. --- --------------------- ------------------------------------- c) Price(s) Price(s) Volume(s) and volume(s) --------------- ---------- 1. Nil cost 1. 9,778 --------------- ---------- 2. ZAR 130.44 2. 9,778 --------------- ---------- --- --------------------- ------------------------------------- d) Aggregated 1. 9,778 information Aggregated 2. 9,778 volume Price 1. Nil cost 2. ZAR 130.44 --- --------------------- ------------------------------------- e) Date of the 1 June 2017 transaction --- --------------------- ------------------------------------- f) Place of Johannesburg Stock Exchange the transaction --- --------------------- ------------------------------------- 1. Details of PDMR / person closely associated with them ("PCA") --- ------------------------------------------------------------ a) Name Dr Thorsten Ole Wiesinger --- --------------------- ------------------------------------- 2. Reason for the notification --- ------------------------------------------------------------ a) Position Chief Executive Officer - Hirslanden / status --- --------------------- ------------------------------------- b) Initial notification Initial Notification / amendment --- --------------------- ------------------------------------- 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- ------------------------------------------------------------ a) Name Mediclinic International plc --- --------------------- ------------------------------------- b) LEI 2138002S5BSBIZTD5I60 --- --------------------- ------------------------------------- 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- ------------------------------------------------------------ a) Description Ordinary Shares of the financial instrument GB00B8HX8Z88 Identification Code --- --------------------- ------------------------------------- b) Nature of Vesting of conditional right to the transaction 17,506 Shares under the Country Schedule to the Forfeitable Share Plan on 31 July 2014 --- --------------------- ------------------------------------- c) Price(s) Price(s) Volume(s) and volume(s) ---------- ---------- Nil cost 17,506 ---------- ---------- --- --------------------- ------------------------------------- d) Aggregated 17,506 information Nil cost Aggregated volume Price --- --------------------- ------------------------------------- e) Date of the 5 June 2017 transaction --- --------------------- ------------------------------------- f) Place of Johannesburg Stock Exchange the transaction --- --------------------- ------------------------------------- 1. Details of PDMR / person closely associated with them ("PCA") --- ----------------------------------------------------------- a) Name Dr Carel A van der Merwe --- --------------------- ------------------------------------ 2. Reason for the notification --- ----------------------------------------------------------- a) Position Chief Clinical Officer of the / status Company --- --------------------- ------------------------------------ b) Initial notification Initial Notification / amendment --- --------------------- ------------------------------------ 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- ----------------------------------------------------------- a) Name Mediclinic International plc --- --------------------- ------------------------------------ b) LEI 2138002S5BSBIZTD5I60 --- --------------------- ------------------------------------ 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- ----------------------------------------------------------- a) Description Ordinary Shares of the financial instrument GB00B8HX8Z88 Identification Code --- --------------------- ------------------------------------ b) Nature of 1. Vesting of award over 16,507 the transaction ordinary shares awarded under the Company's Forfeitable Share Plan 2. Sale of 16,507 ordinary shares. --- --------------------- ------------------------------------ c) Price(s) Price(s) Volume(s) and volume(s) --------------- ---------- 1. Nil cost 1. 16,507 --------------- ---------- 2. ZAR 130.44 2. 16,507 --------------- ---------- --- --------------------- ------------------------------------ d) Aggregated 1. 16,507 information Aggregated 2. 16,507 volume Price 1. Nil cost 2. ZAR 130.44 --- --------------------- ------------------------------------ e) Date of the 1 June 2017 transaction --- --------------------- ------------------------------------ f) Place of Johannesburg Stock Exchange the transaction --- --------------------- ------------------------------------
About Mediclinic International plc
Mediclinic is an international private healthcare group with operating platforms in Southern Africa (South Africa and Namibia), Switzerland and the United Arab Emirates. Its core purpose is to enhance the quality of life of patients by providing acute care, specialist-orientated, multi-disciplinary healthcare services. Mediclinic also holds a 29.9% interest in Spire Healthcare Group plc, a LSE listed and UK-based private healthcare group.
Mediclinic comprises 74 hospitals and 37 clinics. Mediclinic Southern Africa operates 49 hospitals and 2 day clinics throughout South Africa and 3 hospitals in Namibia with more than 8 000 inpatient beds in total; Hirslanden operates 16 private acute care facilities and 4 clinics in Switzerland with more than 1 600 inpatient beds; and Mediclinic Middle East operates 6 hospitals and 31 clinics with more than 700 inpatient beds in the United Arab Emirates.
During February 2016, the combination of the Company (previously named Al Noor Hospitals Group plc), with operations mainly in Abu Dhabi in the United Arab Emirates, and Mediclinic International Limited was completed. Mediclinic International Limited was a South African based international private healthcare group founded in 1983 and listed on the JSE, the South African stock exchange, since 1986, with operations in South Africa, Namibia, Switzerland and the United Arab Emirates (mainly in Dubai). The combination resulted in the renaming of the enlarged group to Mediclinic International plc.
Mediclinic has a primary listing on the Main Market of the LSE, with secondary listings on the JSE in South Africa and the NSX in Namibia.
For further information, please contact:
Capita Company Secretarial Services Limited
Victoria Dalby
+44 (0)207 954 9600
Investor Relations, Mediclinic International plc
James Arnold, Head of Investor Relations
ir@mediclinic.com
+44 (0)20 3786 8181
Media queries
FTI Consulting
Brett Pollard/Debbie Scott (UK)
+44 (0)20 3727 1000
Frank Ford (South Africa)
+27 (0)21 487 9000
Registered address: 1st Floor, 40 Dukes Place, London, EC3A 7NH, United Kingdom
Website: www.mediclinic.com
Corporate broker: Morgan Stanley & Co International plc
JSE sponsor: RAND MERCHANT BANK (A division of FirstRand Bank Limited)
NSX sponsor: Simonis Storm Securities (Pty) Ltd
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHBLGDLXXGBGRL
(END) Dow Jones Newswires
June 06, 2017 12:42 ET (16:42 GMT)
1 Year Mediclinic Chart |
1 Month Mediclinic Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions